Differential effects of cocaine-induced seizures and lethality on M(1)-like muscarinic and dopaminergic D (1)- and D (2)-like binding receptors in mice brain.

Cellular and Molecular Neurobiology
Danielle Silveira MacêdoFrancisca Cléa Florençode Sousa

Abstract

This work was designed to study the changes produced by cocaine-induced seizures and lethality on dopaminergic D(1)- and D(2)-like receptors, muscarinic M(1)-like binding sites, as well as acetylcholinesterase activity in mice prefrontal cortex (PFC) and striatum (ST). Binding assays were performed in brain homogenates from the PFC and ST and ligands used were [(3)H]-N-methylscopolamine, [(3)H]-NMS (in the presence of carbachol), [(3)H]-SCH 23390 and [(3)H]-spiroperidol (in presence of mianserin), for muscarinic (M(1)-like), D(1)- and D(2)-like receptors, respectively. Brain acetylcholinesterase (AChE) activity was also determined in these brain areas. Cocaine-induced SE decreased [(3)H]-SCH 23390 binding in both ST and PFC areas. A decrease in [(3)H]-NMS binding and an increase in [(3)H]-spiroperidol binding in PFC was also observed. Cocaine-induced lethality increased [(3)H]-spiroperidol binding in both areas and decreased [(3)H]-NMS binding only in PFC, while no difference was seen in [(3)H]-SCH 23390 binding. Neither SE, nor lethality altered [(3)H]-NMS binding in ST. AChE activity increased after SE in ST while after death the increase occurred in both PFC and ST. In conclusion, cocaine-induced SE and lethality produces di...Continue Reading

References

Mar 19, 1991·European Journal of Pharmacology·P BaroneG Campanella
Oct 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D K GrandyO Civelli
Jan 1, 1990·Neuroscience·P BaroneT N Chase
Mar 1, 1990·The Journal of Comparative Neurology·R P GaykemaJ Traber
Nov 15, 1986·The Journal of Comparative Neurology·K Satoh, H C Fibiger
Oct 27, 1980·Brain Research·J A FerrendelliR A Gross
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·C CepedaM S Levine
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·Y Y Huang, E R Kandel
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·J F SmileyP S Goldman-Rakic
May 26, 1998·Developmental Neuroscience·C Cepeda, M S Levine
Feb 24, 2001·The Journal of Pharmacy and Pharmacology·K A FosterK L Audus
Feb 12, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Joseph Hallett, Louise Kiessling
Jul 13, 2002·Pharmacology & Therapeutics·David Weinshenker, Patricia Szot
Dec 6, 2002·Journal of Neurophysiology·Jorge Flores-HernándezMichael S Levine
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Oct 7, 2003·Epilepsy & Behavior : E&B·Maria-Teresa HernandezMaryse Lassonde
Mar 31, 2004·Cellular and Molecular Neurobiology·D S MacêdoF C F Sousa
Dec 8, 2004·Epilepsy & Behavior : E&B·Danielle Silveira MacêdoFrancisca Cléa Florenço de Sousa
Aug 9, 2005·Neuroscience Letters·Danielle Silveira MacêdoFrancisca Cléa Florenço de Sousa

❮ Previous
Next ❯

Citations

Oct 14, 2009·Neurochemistry International·Danielle Silveira MacêdoFrancisca Cléa Florenço de Sousa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.